文献速递肾小球疾病

CD44在实验性新月体肾小球肾炎和塌陷性FSGS发病中必需

CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis.
PubMed 文献 · Kidney Int · 2017-12-21

本研究在CD44缺陷小鼠中评估CD44在实验性新月体肾小球肾炎和塌陷性局灶节段性肾小球硬化中的作用。结果显示CD44缺陷小鼠白蛋白尿显著降低,肾小球Ki67阳性增殖细胞减少,新月体肾炎病变数减少,塌陷性FSGS球外增殖病变较小。体外实验表明CD44缺陷壁上皮细胞生长减少,抗CD44抗体可抑制人壁上皮细胞迁移。

要点

  • CD44缺陷减轻两种模型的白蛋白尿和肾小球细胞增殖。
  • CD44阳性增殖细胞可能是壁上皮细胞,在瘢痕性肾小球疾病中起关键作用。
  • 抗CD44抗体可抑制人壁上皮细胞迁移,提示潜在治疗靶点。

核心结论

  • CD44阳性增殖性肾小球细胞(最可能为壁上皮细胞)在瘢痕性肾小球疾病发病中必需。

研究设计与样本

  • 在CD44缺陷(cd44-/-)和野生型小鼠中评估实验性新月体肾小球肾炎和转基因抗Thy1.1塌陷性FSGS模型。

主要发现

  • 两种模型中cd44-/-小鼠白蛋白尿较野生型显著降低。
  • cd44-/-小鼠肾小球Ki67阳性增殖细胞显著减少,新月体肾炎肾小球病变数减少。
  • 塌陷性FSGS中cd44-/-小鼠球外增殖细胞病变较小,但肾小球病变数与野生型无差异。
  • 新月体肾炎中粒细胞和巨噬细胞浸润无差异。
  • 体外CD44缺陷小鼠壁上皮细胞生长减少,抗CD44抗体可抑制人壁上皮细胞迁移。

临床怎么用

  • CD44及其介导的壁上皮细胞活化可能成为瘢痕性肾小球疾病的治疗靶点。

局限性

  • 研究为动物模型和体外实验,尚未在人体验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A key feature of glomerular diseases such as crescentic glomerulonephritis and focal segmental glomerulosclerosis is the activation, migration and proliferation of parietal epithelial cells. CD44-positive activated parietal epithelial cells have been identified in proliferative cellular lesions in glomerular disease. However, it remains unknown whether CD44-positive parietal epithelial cells contribute to the pathogenesis of scarring glomerular diseases. Here, we evaluated this in experimental crescentic glomerulonephritis and the transgenic anti-Thy1.1 model for collapsing focal segmental glomerulosclerosis in CD44-deficient (cd44-/-) and wild type mice. For both models albuminuria was significantly lower in cd44-/- compared to wild type mice. The number of glomerular Ki67-positive proliferating cells was significantly reduced in cd44-/- compared to wild type mice, which was associated with a reduced number of glomerular lesions in crescentic glomerulonephritis. In collapsing focal segmental glomerulosclerosis, the extracapillary proliferative cellular lesions were smaller in cd44-/- mice, but the number of glomerular lesions was not different compared to wild type mice. For crescentic glomerulonephritis the influx of granulocytes and macrophages into the glomerulus was similar. In vitro, the growth of CD44-deficient murine parietal epithelial cells was reduced compared to wild type parietal epithelial cells, and human parietal epithelial cell migration could be inhibited using antibodies directed against CD44. Thus, CD44-positive proliferating glomerular cells, most likely parietal epithelial cells, are essential in the pathogenesis of scarring glomerular disease.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Eymael J, Sharma S, Loeven MA, et al. CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis. Kidney Int. 2017. PMID: 29276101. doi:10.1016/j.kint.2017.09.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。